INSM - Company ID 0001104506
INSMED Inc trades as INSM and has a market capitalization of $25.57 B, making it the #535 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $606.42M, up 66.7% from the prior year and net income of -$1.28B. This page tracks INSMED Inc through 1,774 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Net profit margin expanded from -3297.2% to -210.5% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| Insider sale notice | 144 | 2026-05-18 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
Get to know Insmed, see what drives us, and learn how we’re building a company where people come first.
Get to know Insmed, see what drives us, and learn how we’re building a company where people come first.
Get to know Insmed, see what drives us, and learn how we’re building a company where people come first.
Get to know Insmed, see what drives us, and learn how we’re building a company where people come first.
The largest companies sharing INSMED Inc's SEC industry classification (pharmaceutical preparations).
INSMED Inc (INSM) has a market capitalization of $25.57 B as of 2026-07-09, ranking #535 among US-listed companies.
INSMED Inc reported revenue of $606.42M for fiscal year 2025, an increase of 66.7% year over year.
In its latest fiscal year INSMED Inc reported a net loss of $1.28B.